Briefings in BioinformaticsCancer BiologyPeer-reviewed journal article
Data Imbalance in Drug Response Prediction - Multi-Objective Optimization Approach in Deep Learning Setting
O. Narykov, Y. Zhu, T. Brettin, Y. A. Evrard, A. Partin, F. Xia, M. Shukla, P. Vasanthakumari, J. H. Doroshow, R. L. Stevens
Abstract
Drug response prediction (DRP) methods tackle the complex task of associating the effectiveness of small molecules with the specific genetic makeup of the patient. Anti-cancer DRP is a particularly challenging task requiring costly experiments as underlying pathogenic mechanisms are broad and associated with multiple genomic pathways. The scientific community has exerted significant efforts to generate public drug screening datasets, giving a path to various machine learning (ML) models that attempt to reason over complex data space of small compounds and biological characteristics of tumors. However, the data depth is still lacking compared to computer vision or natural language processing domains, limiting current learning capabilities. To combat this issue and increase the generalizability of the DRP models, we are exploring strategies that explicitly address the imbalance in the DRP datasets. We reframe the problem as a multi-objective optimization across multiple drugs to maximize deep learning model performance. We implement this approach by constructing Multi-Objective Optimization Regularized by Loss Entropy (MOORLE) loss function and plugging it into a Deep Learning model. We demonstrate the utility of proposed drug discovery methods and make suggestions for further potential application of the work to promote equitable outcomes in the healthcare field. Availabilityhttps://github.com/AlexandrNP/MOORLE Contactonarykov@anl.gov
- assay: proteomics
- assay: metagenomics
- research focus: drug response / drug discovery
- research focus: benchmarking
- approach: deep learning
- approach: optimal transport
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Drug Response Prediction and Biomarker Discovery Using Multi-Modal Deep Learning
Farzan Taj, Lincoln David Stein·Bioinformatics AdvancesPeer-reviewed·Jan 1, 2024
- Understanding the Sources of Performance in Deep Drug Response Models Reveals Insights and Improvements
Nikhil Branson, Pedro R. Cutillas, Conrad Bessant·BioinformaticsPeer-reviewed·Jul 1, 2025
- JavaDL: a Java-based Deep Learning Tool to Predict Drug Responses
Beibei Huang, Lon Wolf R. Fong, … Shuxing Zhang·bioRxiv·May 4, 2020
- Monotherapy cancer drug-blind response prediction is limited to intraclass generalization
William G. Herbert, Nicholas Chia, … Marina R. S. Walther-Antonio·PLoS Computational BiologyPeer-reviewed·Apr 22, 2026
- DrugOrchestra: Jointly predicting drug response, targets, and side effects via deep multi-task learning
Yuepeng Jiang, Stefano Rensi, … Russ Biagio Altman·bioRxiv·Nov 17, 2020
- From Hype to Health Check: Critical Evaluation of Drug Response Prediction Models with DrEval
Judith Bernett, Pascal Iversen, … Markus List·bioRxiv·May 26, 2025